Clinical Trial Update: Safety and Efficacy Study of Adalimumab in the Treatment of Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial results update showing safety and efficacy of adalimumab in treating plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2015-01-19